- Trials with a EudraCT protocol (52)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
52 result(s) found for: Becquerel.
Displaying page 1 of 3.
| EudraCT Number: 2019-004119-30 | Sponsor Protocol Number: IP-AVV2019 | Start Date*: 2020-01-08 |
| Sponsor Name:Instituto Palacios | ||
| Full Title: EVALUATION OF THE ACCEPTABILITY AND EFFICACY OF 10 MICROGRAMS OF ESTRADIOL VAGINAL TABLETS VS PROMESTRIENE VAGINAL CREAM | ||
| Medical condition: VULVOVAGINAL ATROPHY | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000445-51 | Sponsor Protocol Number: CHB17.01 | Start Date*: 2018-03-23 |
| Sponsor Name:Centre Henri Becquerel | ||
| Full Title: Efficiency of an antibioprophylaxy (levofloxacin) in patient treated by azacitidine | ||
| Medical condition: myelodysplastic syndrome or acute myeloid leukeamia | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-006491-30 | Sponsor Protocol Number: CHB 08 03 | Start Date*: 2009-02-06 |
| Sponsor Name:Centre Henri Becquerel | ||
| Full Title: Etude prospective, multicentrique, de phase II testant la faisabilité d’un traitement d’entretien par l’alemtuzumab chez des patients porteurs de leucémie lymphoïde chronique, traités et répondant ... | ||
| Medical condition: Chronic lymphoid leukemia in complete remission (CR) or partial remission (PR) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004128-32 | Sponsor Protocol Number: KZM-PSMA-01 | Start Date*: 2017-12-01 |
| Sponsor Name:Fakultní nemocnice Plzeň | ||
| Full Title: Imaging of the prostate tumors using PET/CT and PET/MRI with the ligand of the prostatic specific membrane antigene 68Ga-PSMA-11 | ||
| Medical condition: prostatic carcinoma higly suspected or its staging or restaging | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-023831-40 | Sponsor Protocol Number: I124 | Start Date*: 2011-04-12 | |||||||||||
| Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO | |||||||||||||
| Full Title: Study for metastatic thyroid cancer using 124i and [18F] FDG PET / CT in patients with elevated values of Tg and / or AbTg with negative ultrasonography of the neck, previously treated with thyroid... | |||||||||||||
| Medical condition: Only patiens | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-002310-12 | Sponsor Protocol Number: IN-ES-380-4663 | Start Date*: 2018-11-19 |
| Sponsor Name:Fundació Lluita contra la SIDA | ||
| Full Title: Bictegravir concentrations and antiviral activity in genital fluids and rectal compartment in HIV-1 infected individuals (“BIGER Study”). | ||
| Medical condition: HIV-1 infected male and female adults not previously exposed to ART. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-002093-40 | Sponsor Protocol Number: 104902 | Start Date*: 2017-08-30 |
| Sponsor Name:Radboudumc | ||
| Full Title: 68Ga-PSMA-PET/CT imaging for locally advanced, recurrent and metastatic adenoid cystic carcinoma or salivary duct carcinoma | ||
| Medical condition: Patients with locally advanced, recurrent or metastatic adenoid cystic carcinoma or salivary duct carcinoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-001028-16 | Sponsor Protocol Number: EARLY-DEX | Start Date*: 2021-05-21 |
| Sponsor Name:Fundación para la Investigación e Innovación Biomédica (FIIB) del Hospital Universitario Infanta Leonor y Hospital Unive | ||
| Full Title: DEXamethasone EARLY administration in hospitalized patients with Covid-19 pneumonia and high risk of developing acute respiratory distress syndrome | ||
| Medical condition: Hospitalized patients with Covid-19 pneumonia who do not require oxygen therapy on admission associated with at least two of the three following factors related with severe Covid-19: lactate dehydr... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-001016-30 | Sponsor Protocol Number: NODAGA-RGD-2 | Start Date*: 2018-12-11 |
| Sponsor Name:Department of Nuclear Medicine, Medical University Innsbruck | ||
| Full Title: PROSPECTIVE STUDY OF 68GA-NODAGA-RGD-PET FOR THE NON-INVASIVE DETERMINAITON OF THE INTEGRIN αvβ3 EXPRESSION IN PATIENTS WITH UNTREATED OR RECURRENT BREAST CANCER, COLORECTAL CANCER, NON-SMALL CELL ... | ||
| Medical condition: Patient with untreated or reccurent breast cancer, non-small cell lung cancer, colorectal cancer and neuroendocrine tumors | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-003124-12 | Sponsor Protocol Number: B-40320109424 | Start Date*: 2012-10-30 |
| Sponsor Name:Cliniques Universitaires Saint Luc | ||
| Full Title: A prospective phase II study on dose escalation using PET based adaptive IMRT stage II-III non small lung cancer | ||
| Medical condition: Stage II-III Non small lung cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-000375-13 | Sponsor Protocol Number: LIS-144 | Start Date*: 2011-05-02 |
| Sponsor Name:National Institute of Public Health and Environment (RIVM, the Netherlands) | ||
| Full Title: Study to determine the appropriate age for a second immunization with the Meningococcal C conjugated vaccine. | ||
| Medical condition: The vaccin administered in this study is used to prevent invasive disease caused by Meningococcal serogroup C. | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-005373-58 | Sponsor Protocol Number: 82/2007/O/Sper | Start Date*: 2007-09-18 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
| Full Title: EVALUATION OF DIAGNOSTIC ACCURACY OF 68GA-CITRATE PET/CT IN PATIENTS WITH INFLAMMATORY-INFECTIOUS DISEASES. | |||||||||||||
| Medical condition: Inflammatory disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-000483-42 | Sponsor Protocol Number: 001 | Start Date*: 2016-05-19 |
| Sponsor Name:ISPPCC - CHU Chrarleroi - Hôpital Civil Marie Curie - Clinique du Sein | ||
| Full Title: Clinical, operating, prospective, academy, study of not inferiority of the Green Indocyanine (ICG) marking method, versus the radio-isotopic method, of sentinel nodes in breast. | ||
| Medical condition: Axillar sentinel node research in Breast Cancer staging. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-000504-17 | Sponsor Protocol Number: ML 20073 | Start Date*: 2006-06-12 |
| Sponsor Name:Heinrich-Heine-Universität Düsseldorf | ||
| Full Title: Konsekutive Aderlass- und Peginterferon alfa-2a -Ribavirin-Standardtherapie im Vergleich zu einer Peginterferon alfa-2a-Ribavirin-Standardtherapie bei naiven Patienten mit HCV Genotyp 1 und Ferriti... | ||
| Medical condition: Chronische Hepatitis C Infektion | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-023935-41 | Sponsor Protocol Number: PET-BRCA-2010 | Start Date*: 2011-03-22 |
| Sponsor Name:Consorcio de Apoyo a la Investigación Biomédica en Red (CAIBER) | ||
| Full Title: PILOT STUDY ASSESSING THE EFFECTIVENESS OF 18FDG PET-CT IN THE EARLY DIAGNOSIS OF BREAST CANCER AND / OR OVARIAN CANCER IN WOMEN BRCA1 or BRCA 2 MUTATION CARRIERS | ||
| Medical condition: Breast cancer screening in women BRCA1 or BRCA2 mutation. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001697-30 | Sponsor Protocol Number: COVIDNA | Start Date*: 2020-04-23 |
| Sponsor Name:NAVARRABIOMED - FUNDACIÓN MIGUEL SERVET | ||
| Full Title: PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA) | ||
| Medical condition: PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19 | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-003398-24 | Sponsor Protocol Number: OAB/AB/07 | Start Date*: 2008-01-21 | |||||||||||
| Sponsor Name:The Whittington Hospital NHS Trust | |||||||||||||
| Full Title: A randomised, double blind validation of the significance of occult pyuria for the symptoms of the overactive bladder | |||||||||||||
| Medical condition: The overactive bladder | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-015782-30 | Sponsor Protocol Number: APOSTELIII | Start Date*: 2012-11-23 | |||||||||||
| Sponsor Name:Academic Medical Centre | |||||||||||||
| Full Title: Nifedipine versus Atosiban in the treatment of threatened preterm labour | |||||||||||||
| Medical condition: Threatened preterm labour | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-002085-31 | Sponsor Protocol Number: RAD-ON02 | Start Date*: 2017-11-14 |
| Sponsor Name:Kurort Forschungsverein Bad Steben e.V. | ||
| Full Title: Determining the immunological and pain reducing effects of serial radon balneology in patients with musculoskeletal disorders. | ||
| Medical condition: Chronic degenerative spine and/or joint disorders with pain perception of at least 1 year and pain intensity on visual analogue scale ≥4 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-004545-15 | Sponsor Protocol Number: MLAM 2007/01 | Start Date*: 2008-06-10 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: The Split Dose Study: Split dose Rhenium-188-HEDP regimen in hormone refractory prostate cancer patients with bone metastases; a phase I toxicity study and phase II efficacy study. | ||
| Medical condition: Hormone refractory prostate cancer with painful bone metastases | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
